Venøs tromboembolisme Hyppigheden af venøse tromboemboliske hændelser i kliniske studier var den samme for patienter, som fik Avastin i kombination med kemoterapi, sammenlignet med dem, som fik kemoterapi alene.
The incidence of venous thromboembolic events in clinical trials was similar in patients receiving Avastin in combination with chemotherapy compared to those receiving the control chemotherapy alone.